Clinical Trial Update: The Potential Hepatoprotective Effect of Metformin in Patients With Beta Thalassemia Major [Phase 4]

View source ↗

Summary

This document covers a Phase 4 clinical trial evaluating whether metformin has hepatoprotective effects in patients with beta-thalassemia major. The current sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta Thalassemia Major

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Cairo University | Conditions: Beta Thalassemia Major Anemia | Phase 4 | Status: UNKNOWN